Cancer Treatment Reviews
Volume 37, Issue 3 , Pages 208-211, May 2011

Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: Current role and future perspectives

  • Lucia Del Mastro

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +39 0105600666; fax: +39 0105600850.
    • ,
  • Alessia Levaggi

      Affiliations

    • Tel.: +39 0105600666; fax: +39 0105600850.
    • ,
  • Sara Giraudi

      Affiliations

    • Tel.: +39 0105600898; fax: +39 0105600850.
    • ,
  • Paolo Pronzato

      Affiliations

    • Tel.: +39 0105600668; fax: +39 0105600850.

Department of Medical Oncology, National Cancer Research Institute, Largo Rosanna Benzi 10, 16132 Genoa, Italy

Received 29 June 2010; received in revised form 23 July 2010; accepted 23 July 2010. published online 19 August 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(10)00134-9

doi:10.1016/j.ctrv.2010.07.007

Cancer Treatment Reviews
Volume 37, Issue 3 , Pages 208-211, May 2011

Article Tools